Hendrik J. Thibaut

Leuven, VLG 3000, Belgium

Last Updated: 09/26/2026

Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 51 publications

Rational Design of a Chimpanzee Adenoviral-Vector Vaccine Against Yellow Fever Through the Modification of Antigen Transmembrane Domains.

Rational Design of a Chimpanzee Adenoviral-Vector Vaccine Against Yellow Fever Through the Modification of Antigen Transmembrane Domains.

Journal: Vaccines
Published: February 28, 2026

4-Octyl itaconate blocks STAT3-induced ACE2 expression to reduce uptake of SARS-CoV-2.

4-Octyl itaconate blocks STAT3-induced ACE2 expression to reduce uptake of SARS-CoV-2.

Journal: Biochemical pharmacology
Published: January 28, 2026

The multifaceted role of the viral 2A protease in enterovirus replication and antagonism of host antiviral responses.

The multifaceted role of the viral 2A protease in enterovirus replication and antagonism of host antiviral responses.

Journal: PLoS pathogens
Published: March 23, 2025

Antigenic Imprinting Dominates Humoral Responses to New Variants of SARS-CoV-2 in a Hamster Model of COVID-19.

Antigenic Imprinting Dominates Humoral Responses to New Variants of SARS-CoV-2 in a Hamster Model of COVID-19.

Journal: Microorganisms
Published: October 11, 2024

Parallel Multifactorial Process Optimization and Intensification for High-Yield Production of Live YF17D-Vectored Zika Vaccine.

Parallel Multifactorial Process Optimization and Intensification for High-Yield Production of Live YF17D-Vectored Zika Vaccine.

Journal: Vaccines
Published: May 20, 2024

Validation of a Reporter Cell Line for Flavivirus Inhibition Assays.

Validation of a Reporter Cell Line for Flavivirus Inhibition Assays.

Journal: Microbiology spectrum
Published: February 14, 2023

Optimized vaccine candidate MVA-S(3P) fully protects against SARS-CoV-2 infection in hamsters.

Optimized vaccine candidate MVA-S(3P) fully protects against SARS-CoV-2 infection in hamsters.

Journal: Frontiers in immunology
Published: February 10, 2023

Multiplexed multicolor antiviral assay amenable for high-throughput research.

Multiplexed multicolor antiviral assay amenable for high-throughput research.

Journal: Nature communications
Published: February 09, 2023

YF17D-vectored Ebola vaccine candidate protects mice against lethal surrogate Ebola and yellow fever virus challenge.

YF17D-vectored Ebola vaccine candidate protects mice against lethal surrogate Ebola and yellow fever virus challenge.

Journal: NPJ vaccines
Published: January 13, 2023

Development of a robust and convenient dual-reporter high-throughput screening assay for SARS-CoV-2 antiviral drug discovery.

Development of a robust and convenient dual-reporter high-throughput screening assay for SARS-CoV-2 antiviral drug discovery.

Journal: Antiviral research
Published: November 28, 2022

TMEM106B is a receptor mediating ACE2-independent SARS-CoV-2 cell entry.

TMEM106B is a receptor mediating ACE2-independent SARS-CoV-2 cell entry.

Journal: Cell
Published: November 14, 2022

FLUIDOT: A Modular Microfluidic Platform for Single-Cell Study and Retrieval, with Applications in Drug Tolerance Screening and Antibody Mining.

FLUIDOT: A Modular Microfluidic Platform for Single-Cell Study and Retrieval, with Applications in Drug Tolerance Screening and Antibody Mining.

Journal: Small methods
Published: November 11, 2022
Showing 1-12 of 51

Last Updated: 09/26/2026